Clinical Protocol Management
临床方案管理
基本信息
- 批准号:7714131
- 负责人:
- 金额:$ 9.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-09-01 至 2012-11-30
- 项目状态:已结题
- 来源:
- 关键词:AdherenceAdministratorAdoptionAdverse eventAdverse reactionsAreaArizonaBudgetsCalendarCaliforniaCancer CenterCancer Center Support GrantCareer LaddersCell TransplantationCitiesClinicalClinical Practice GuidelineClinical ProtocolsClinical ResearchClinical Research AssociateClinical TrialsCollaborationsCommunicable DiseasesConduct Clinical TrialsContinuing EducationDailyDataData CollectionData QualityDevelopmentDiseaseDoctor of PhilosophyDocumentationEducationEligibility DeterminationEnrollmentEnsureEquilibriumEvaluationFeesGoalsHematologyHousingIndividualInformation ManagementInformation SciencesInformed ConsentInternetInvestigational DrugsMaintenanceMalignant NeoplasmsMedicalMedical OncologyMentorsMonitorNamesNational Surgical Adjuvant Breast and Bowel ProjectNatureOperative Surgical ProceduresOutcomes ResearchPatient CarePatientsPediatricsPeer ReviewPerformancePerformance StatusPhasePoliciesPopulation SciencesPreparationProceduresProtocols documentationPublicationsQuality ControlRadiation OncologyRadioimmunotherapyReactionReportingResearch Ethics CommitteesResearch PersonnelResearch SupportResource SharingResourcesServicesSiteSourceSpecialistStandards of Weights and MeasuresSupervisionSurgical OncologyTrainingUnited States Food and Drug AdministrationWorkloadanticancer researchcancer diagnosisdata managementdesigndrug developmentfollow-upmemberneuro-oncologyoutreachoutreach programprogramsquality assurance
项目摘要
The goal of the Clinical Protocol Management Core (CPMC) is to provide protocol administration and data
management services. The CPMC is directed by Joyce Niland, PhD, Cancer Center Associate Director for
Information Sciences and Chair, Division of Information Sciences (DIS); the Core Manager is Dina Johnson,
Director of the Clinical Research Information Management Department within DIS. Specific services include
providing input and review of studies for protocol and data management issues, confirming patient eligibility
and registration on study, managing studies in progress, collecting study data, monitoring regulatory
compliance, assisting with IRB submissions, ensuring timely reporting of adverse reactions, assisting with
preparation of data for study analyses, and participating in continuing education, and quality assurance
procedures. All of these are carried out in compliance with FDA Good Clinical Practices (GCP). The CPMC
staff provides research support for all clinical departments at City of Hope, including Hematology &
Hematopoeitic Cell Transplantation (HCT), Medical Oncology, Surgical Oncology, Pediatrics, Infectious
Disease, Neuro-oncology, Radioimmunotherapy, Radiation Oncology, Population Sciences. The CPMC also
provides data coordinating services for the NSABP Outreach Program, Phase 11\\ new drug development
through the California Cancer Consortium-Pittsburgh trials, the COH Pasadena Outreach Office, and the
Arizona Good Samaritan HCT Program. Daily supervision of the CPMC Clinical Research Associates
(CRAs) is provided by the Core Manager/Department Director and two Clinical Trial Administrators who
report to her. Quality Control Coordinators assist in training, reviewing data, and conducting Protocol
Adherence Evaluations of in-house trials. Operations Specialists assist with policies and procedures, forms
design, protocol reporting and maintenance of the Clinical Trials On-Line Web site. Two Senior Data Entry
Clerks provide entry of protocol data as well as protocol specific results. In Fiscal Year (FY) 2006, CPMC
provided the abovementioned services for 551 cancer-related protocols. 2,073 patients were accrued to
protocols managed by CPMC, with 7,854 patients in follow-up. From 2002-2006 over 170 publications and
cancer research presentations utilized data collected and quality controlled by the CPMC. During the
FY2006 reporting period, the CPMC was utilized by 64 Cancer Center members from 5 programs. Peerreviewed
usage represented 92.5% (1,918/2,073 patient accruals) of the total CPMC usage. Annual budget
for the core is $5,308,224, comprising 25% institutional support, 5% user fees, and 68% other. The CCSG
request is for 2% ($131,000).
临床方案管理核心 (CPMC) 的目标是提供方案管理和数据
管理服务。 CPMC 由 Joyce Niland 博士、癌症中心副主任指导
信息科学和信息科学部 (DIS) 系主任;核心经理是迪娜·约翰逊,
DIS 临床研究信息管理部主任。具体服务包括
提供研究方案和数据管理问题的输入和审查,确认患者的资格
研究和注册、管理正在进行的研究、收集研究数据、监测监管
合规性,协助 IRB 提交,确保及时报告不良反应,协助
准备研究分析数据、参与继续教育和质量保证
程序。所有这些都是按照 FDA 良好临床实践 (GCP) 进行的。 CPMC
工作人员为 City of Hope 的所有临床部门提供研究支持,包括血液学和
造血细胞移植 (HCT)、肿瘤内科、肿瘤外科、儿科、感染科
疾病、神经肿瘤学、放射免疫治疗、放射肿瘤学、人口科学。中粮监委还
为 NSABP 外展计划第 11 阶段新药开发提供数据协调服务
通过加州癌症联盟-匹兹堡试验、COH 帕萨迪纳外展办公室和
亚利桑那州好撒玛利亚人 HCT 计划。 CPMC临床研究员的日常监督
(CRA)由核心经理/部门主管和两名临床试验管理员提供,他们
向她报告。质量控制协调员协助培训、审查数据和执行方案
内部试验的依从性评估。运营专家协助制定政策、程序、表格
临床试验在线网站的设计、方案报告和维护。 2.高级数据录入
职员提供协议数据的输入以及协议特定的结果。 2006财年(FY),中粮包装
为551个癌症相关方案提供了上述服务。累计 2,073 名患者
由 CPMC 管理的方案,有 7,854 名患者接受随访。从 2002 年到 2006 年,发表了超过 170 篇出版物
癌症研究报告利用了 CPMC 收集的数据和质量控制。期间
2006 财年报告期间,来自 5 个项目的 64 名癌症中心成员使用了 CPMC。同行评审
使用量占 CPMC 总使用量的 92.5%(1,918/2,073 名患者应计)。年度预算
核心费用为 5,308,224 美元,其中包括 25% 的机构支持、5% 的用户费用和 68% 的其他费用。 CCSG
请求金额为 2%(131,000 美元)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
THEODORE G KRONTIRIS其他文献
THEODORE G KRONTIRIS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('THEODORE G KRONTIRIS', 18)}}的其他基金
相似海外基金
Intensive Combination Approach to Rollback the HIV Epidemic in Nigerian Youth (iCARE) Plus Effectiveness / Implementation Hybrid Study
遏制尼日利亚青少年艾滋病毒流行的强化组合方法 (iCARE) 加上有效性/实施混合研究
- 批准号:
10749347 - 财政年份:2023
- 资助金额:
$ 9.3万 - 项目类别:
Randomized Control Trial of Positive Peers mHealth app as a clinic-based intervention to optimize HIV outcomes among young, minority persons living with HIV
积极同伴移动医疗应用程序的随机对照试验作为一种基于临床的干预措施,以优化年轻的少数族裔艾滋病毒感染者的艾滋病毒结果
- 批准号:
10819912 - 财政年份:2023
- 资助金额:
$ 9.3万 - 项目类别:
Enhancing K-12 School Safety During a Respiratory Viral Pandemic
在呼吸道病毒大流行期间加强 K-12 学校安全
- 批准号:
10607291 - 财政年份:2023
- 资助金额:
$ 9.3万 - 项目类别:
Development and Implementation of Optimal Rehabilitation Care Pathways to Reduce Disparities in Rehabilitation Outcomes after Joint Replacement
制定和实施最佳康复护理途径,以减少关节置换后康复结果的差异
- 批准号:
10722471 - 财政年份:2023
- 资助金额:
$ 9.3万 - 项目类别: